Evaluating the Role of Circulating MicroRNAs to Aid Therapeutic Decision Making for Neoadjuvant Chemotherapy in Breast Cancer: A Prospective, Multicenter Clinical Trial
Conclusions:
This study illustrates the potential value of circulatory miRNA measurement in predicting response to NAC. Further interrogation of these findings may see miRNAs personalize therapeutic decision-making for patients undergoing NAC for early breast cancer.
Source: Annals of Surgery - Category: Surgery Tags: ESA Paper Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Genetics | HER2 | Ireland Health | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study | Surgery